These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 35414856)

  • 1. Clinical Clues and Diagnostic Workup of Cardiac Amyloidosis.
    Gill SS; Fellin E; Stampke L; Zhao Y; Masri A
    Methodist Debakey Cardiovasc J; 2022; 18(2):36-46. PubMed ID: 35414856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and clinical manifestations of cardiac amyloidosis.
    Bajwa F; O'Connor R; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates in Cardiac Amyloidosis Diagnosis and Treatment.
    Stern LK; Kittleson MM
    Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis.
    Bravo PE; Dorbala S
    Curr Cardiol Rep; 2017 Jul; 19(7):59. PubMed ID: 28508350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
    Martini N; Rizzo S; Sarais C; Cipriani A
    BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
    Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
    Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
    Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
    Narotsky DL; Castano A; Weinsaft JW; Bokhari S; Maurer MS
    Can J Cardiol; 2016 Sep; 32(9):1166.e1-1166.e10. PubMed ID: 27568874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
    Brownrigg J; Lorenzini M; Lumley M; Elliott P
    ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms.
    Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N
    Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Forms of Cardiac Amyloidosis: Diagnostic Clues and Phenotype in Apo AI and AIV Amyloidosis.
    Ioannou A; Porcari A; Patel RK; Razvi Y; Sinigiani G; Martinez-Naharro A; Venneri L; Moon J; Rauf MU; Lachmann H; Wechelakar A; Hawkins PN; Gillmore JD; Fontana M
    Circ Cardiovasc Imaging; 2023 Jul; 16(7):523-535. PubMed ID: 37431665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
    Driggin E; Maurer MS
    Clin Cardiol; 2020 Feb; 43(2):171-178. PubMed ID: 31825134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
    Vergaro G; Aimo A; Barison A; Genovesi D; Buda G; Passino C; Emdin M
    Eur J Prev Cardiol; 2020 Nov; 27(17):1806-1815. PubMed ID: 31581822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yield of bone scintigraphy screening for transthyretin-related cardiac amyloidosis in different conditions: Methodological issues and clinical implications.
    Tini G; Sessarego E; Benenati S; Vianello PF; Musumeci B; Autore C; Canepa M
    Eur J Clin Invest; 2021 Dec; 51(12):e13665. PubMed ID: 34390490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality Imaging in Cardiac Amyloidosis.
    Giblin GT; Cuddy SAM
    Curr Cardiol Rep; 2021 Aug; 23(10):134. PubMed ID: 34410523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Amyloidosis: Updates in Imaging.
    Chacko L; Martone R; Cappelli F; Fontana M
    Curr Cardiol Rep; 2019 Aug; 21(9):108. PubMed ID: 31375984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.